Abiomed Inc (NASDAQ:ABMD) Sellers Strengthened By 16.74% Their Shorts As Of Dec 8, 2018

ABIOMED, Inc. (NASDAQ:ABMD) Corporate Logo

During 2018 Q2 the big money sentiment increased to 1.61. That’s change of 0.66, from 2018Q1’s 0.95. 19 investors sold all, 131 reduced holdings as ABIOMED, Inc. ratio is positive. 118 rose holdings while 123 funds bought holdings. Funds hold 36.14 million shares thus 0.72% less from 2018Q1’s 36.41 million shares.
Engineers Gate Manager Ltd Partnership has invested 0.46% of its capital in ABIOMED, Inc. (NASDAQ:ABMD). Security accumulated 400 shs. Pension holds 44,744 shs or 0.08% of its capital. Walleye Trading Lc reported 388 shs. Reilly Financial Advsrs Llc holds 101 shs. Commonwealth Of Pennsylvania Public School Empls Retrmt System owns 4,423 shs. Cleararc Cap Incorporated holds 1,087 shs or 0.06% of its capital. Gideon Advsr has invested 0.23% of its capital in ABIOMED, Inc. (NASDAQ:ABMD). Robeco Institutional Asset Mgmt Bv reported 0.05% of its capital in ABIOMED, Inc. (NASDAQ:ABMD). Benjamin F Edwards And Inc holds 0.01% in ABIOMED, Inc. (NASDAQ:ABMD) or 310 shs. Fifth Third Bancorporation reported 0% stake. Norinchukin Retail Bank The owns 4,787 shs. Kentucky Retirement Ins Tru Fund invested in 0.08% or 796 shs. 69,838 were accumulated by Fil Ltd. 500 were reported by Beech Hill Advsrs Inc.

ABIOMED, Inc. had 5 selling transactions and 0 insider buys since June 15, 2018. This’s net activity of $74.93 million. MINOGUE MICHAEL R sold $46.17 million worth of stock. 5,000 shs were sold by Greenfield Andrew J, worth $2.10 million. On Tuesday, September 25 $4.33M worth of ABIOMED, Inc. (NASDAQ:ABMD) was sold by Howley Michael G.

It was registered an increase on Abiomed Inc (NASDAQ:ABMD)’s shares shorted with 16.74%. It was published in December by FINRA the 1.06 million shares shorted on ABMD. That’s 16.74% up from 909,800 shares. With Average volume 447,200, ABMD’s former position will take 2 days to recover. 2.42% is Abiomed Inc float short.

ABMD is reaching $317.52 during the last trading session, after decreased 4.64%.ABIOMED, Inc. has volume of 467,881 shares. Since December 8, 2017 ABMD has risen 148.84% and is uptrending. The stock outperformed the S&P 500 by 133.22%.

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.The firm is worth $14.30 billion. It also provides continuum of care to heart failure patients.76.81 is the P/E ratio. The firm offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter axial flow pump.

ABIOMED, Inc. (NASDAQ:ABMD) Ratings Coverage

A total of 2 analysts rate Abiomed (NASDAQ:ABMD) as follows: 2 “Buy”, 0 “Hold” and 0 “Sell”. Š¢herefore 100% are bullish. (NASDAQ:ABMD) has 3 ratings reports on Dec 8, 2018 according to StockzIntelligence. On Friday, November 2 the stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given by BTIG Research. On Thursday, October 11 Morgan Stanley maintained ABIOMED, Inc. (NASDAQ:ABMD) with “Equal-Weight” rating. On Wednesday, November 7 Morgan Stanley upgraded the shares of ABMD in report to “Overweight” rating.

For more ABIOMED, Inc. (NASDAQ:ABMD) news announced briefly go to: Nasdaq.com, Benzinga.com, Benzinga.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Peek Under The Hood: SDG Has 13% Upside – Nasdaq” announced on November 12, 2018, “54 Stocks Moving In Monday’s Mid-Day Session – Benzinga” on November 12, 2018, “70 Biggest Movers From Yesterday – Benzinga” with a publish date: November 13, 2018, “Here’s Why You Should Invest in Abiomed (ABMD) Right Now – Nasdaq” and the last “Abiomed down 11% despite positive Impella CP data – Seeking Alpha” with publication date: November 12, 2018.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.